Fulcrum Therapeutics, Inc. (FULC)
13.82
-0.78
(-5.38%)
USD |
NASDAQ |
Dec 10, 16:00
13.82
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Market Cap: 747.65M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agios Pharmaceuticals, Inc. | 1.630B |
| Biogen, Inc. | 26.04B |
| CorMedix, Inc. | 904.89M |
| Apellis Pharmaceuticals, Inc. | 3.125B |
| NovaBay Pharmaceuticals, Inc. | 302.43M |
Market Cap Related Metrics
| PEG Ratio | -0.0417 |
| Price to Book Value | 3.769 |
| Price | 13.82 |
| Earnings Yield | -8.54% |
| PEGY Ratio | -0.0417 |